Cargando…

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa

BACKGROUND: Drug resistant-tuberculosis is a growing burden on the South African health care budget. In response the National Department of Health implemented two important strategies in 2011; universal access to drug-sensitivity testing for rifampicin with Xpert MTB/RIF as the first-line diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Rensburg, Craig, Berhanu, Rebecca, Hirasen, Kamban, Evans, Denise, Rosen, Sydney, Long, Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553851/ https://www.ncbi.nlm.nih.gov/pubmed/31170207 http://dx.doi.org/10.1371/journal.pone.0217820

Ejemplares similares

Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study
por: Berhanu, Rebecca, et al.
Publicado: (2016)

Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2018)

Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2018)

Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2017)

Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa
por: Sineke, Tembeka, et al.
Publicado: (2019)

Using a Self-Administered Electronic Adherence Questionnaire to Identify Poor Adherence Amongst Adolescents and Young Adults on First-Line Antiretroviral Therapy in Johannesburg, South Africa
por: Hirasen, Kamban, et al.
Publicado: (2020)

The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

The right combination – treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg, South Africa
por: Hirasen, Kamban, et al.
Publicado: (2017)

The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2014)

Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
por: Onoya, Dorina, et al.
Publicado: (2018)

Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa
por: Onoya, Dorina, et al.
Publicado: (2017)

Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa
por: d'Elia, Alexander, et al.
Publicado: (2015)

Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2018)

Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2016)

Correction: Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2019)

Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa
por: Jamieson, Lise, et al.
Publicado: (2019)

Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa
por: Mokhele, Idah, et al.
Publicado: (2021)

Pneumonic Plague in Johannesburg, South Africa, 1904
por: Evans, Charles M., et al.
Publicado: (2018)

Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa
por: Rosen, Sydney, et al.
Publicado: (2010)

Indoor Temperatures in Low Cost Housing in Johannesburg, South Africa
por: Naicker, Nisha, et al.
Publicado: (2017)

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa
por: Larson, Bruce A, et al.
Publicado: (2010)

Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa
por: Musakwa, Nozipho Orykah, et al.
Publicado: (2021)

The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2013)

HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2020)

Uptake of same-day initiation of HIV treatment in Malawi, South Africa, and Zambia as reported in routinely collected data: the SPRINT retrospective cohort study
por: Huber, Amy, et al.
Publicado: (2023)

Environmental Silica Dust Exposure and Pulmonary Tuberculosis in Johannesburg, South Africa
por: Kootbodien, Tahira, et al.
Publicado: (2019)

Treatment outcomes of over 1000 patients on second‐line, protease inhibitor‐based antiretroviral therapy from four public‐sector HIV treatment facilities across Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2016)

Perceived efficacy of HIV treatment-as-prevention among university students in Johannesburg, South Africa
por: Bor, Jacob, et al.
Publicado: (2021)

Adaptation of WHO’s generic tuberculosis patient cost instrument for a longitudinal study in Africa
por: Evans, Denise, et al.
Publicado: (2021)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data
por: Benade, Mariet, et al.
Publicado: (2022)

Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa
por: Moyo, Faith, et al.
Publicado: (2016)

Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa
por: Leavitt, Sarah V., et al.
Publicado: (2021)

HIV-Associated Disseminated Emmonsiosis, Johannesburg, South Africa
por: van Hougenhouck-Tulleken, Wesley G., et al.
Publicado: (2014)

Sarcoidosis in Johannesburg, South Africa: A retrospective study
por: Morar, R, et al.
Publicado: (2022)

Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
por: Berry, Kaitlyn M., et al.
Publicado: (2019)

Psychosexual experiences of men following radiotherapy for prostate cancer in Johannesburg, South Africa
por: Phahlamohlaka, Matheko N., et al.
Publicado: (2018)

Voices from the front lines: A qualitative study of integration of HIV, tuberculosis, and primary healthcare services in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2020)

High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study
por: Fairlie, Lee, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gg309g96hd4njckfjff2po6252